Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

In both cohorts, higher burden scores correlated with reduced lung function, poorer asthma control, and lower quality of life. Traditional biomarkers like blood eosinophil counts and fractional ...

Higher burden scores correlated with worse lung function, asthma control, and quality of life, and a burden score of 0.15 or lower predicted asthma remission with sensitivity greater than 91% and ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was deemed “best predictor” of 12-month remission in patients with ...